Skip to content

CEOs of Biopharmaceutical Companies CTLT, GSK, INCY, MRK, MRNA, PFE, SNY, TAK, UCB Share Long-Term Business Plans with Investors

NEW YORK, June 7, 2021—Representing $800 billion in market capitalization, nine CEOs from the biopharma sector will speak virtually about their company’s long-term approach to sustainable business, June 7-8, 2021. The Biopharma CEO Investor Forum—co-hosted by Chief Executives for Corporate Purpose© (CECP) and the Biopharma Sustainability Roundtable—is the largest platform for CEOs to address long-term value creation, inclusive of environmental, social, and governance (ESG) topics and stakeholder engagement.

Read more here